Technical guidelines for access and rational use of antiviral drugs and vaccines for influenza A (H1N1) pandemic

PAHO applies the following technical guidelines to help Member States ensure access to and rational use of antiviral drugs in the case of an influenza A (H1N1) pandemic. A complete list of PAHO guidelines and recommendations is available at:

 Extension of shelf of Tamiflu (oseltamivir phosphate)- Roche (29.08 kB)

 Questions and Answers on the availability treatment (18.03 kB)

 PAHO/WHO recommendations to guide planning of needs and management of antiviral drug inventories (Oseltamivir) (73.96 kB)

 Provisional recommendations for management of confirmed or probable patients infected by the influenza A (H1N1) virus and close contacts with antiviral treatment. Version April 30, 2009 (32.28 kB)

* All these documents are available in Spanish only